跳至主要内容
临床试验/2025-524240-35-00
2025-524240-35-00招募中4 期

OFA-VATS : Impact of opioid free anesthesia on postoperative quality of recovery and analgesia after video or robot assisted thoracic surgery

Centre Hospitalier Universitaire De Rennes5 个研究点 分布在 1 个国家目标入组 176 人开始时间: 2026年6月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
176
试验地点
5
主要终点
Score obtained from the self-administered QoR-15 questionnaire at D1 after surgery. The questionnaire will be completed by the patient while blinded to the treatment group

研究概览

简要总结

To compare the effect, in terms of patient-reported quality of recovery on postoperative day 1, of an opioid-free anaesthesia (OFA) protocol versus a standard opioid-based intraoperative protocol in video-assisted (VATS) or robot-assisted thoracic surgery (RATS).

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Adult patient (≥18 years)
  • Indication for pulmonary resection surgery (segmentectomy or lobectomy) performed by video-assisted thoracoscopy or scheduled robot-assisted surgery
  • Use of effective contraception in accordance with CFTG recommendations
  • Having received oral and written information about the study protocol and having provided written informed consent to participate in the research
  • Affiliation with a social security health insurance system

排除标准

  • Emergency surgery
  • Epilepsy not controlled by medical treatment
  • Decompensated respiratory failure (in the absence of mechanical ventilation)
  • Heart failure with left ventricular ejection fraction (LVEF) <40%
  • Obstructive sleep apnea syndrome
  • Concomitant use of buprenorphine, nalbuphine, pentazocine, or naltrexone
  • Preoperative prescription of opioids
  • Bradycardia <40 beats/min
  • Uncontrolled hypotension or shock state
  • Other contraindications to nonsteroidal anti-inflammatory drugs (NSAIDs), including: o Active gastroduodenal ulcer; o History of peptic ulcer disease or recurrent gastrointestinal bleeding (at least two documented episodes); o History of gastrointestinal bleeding or perforation associated with NSAID use.
  • Inability to complete the QoR-15 questionnaire
  • Combined surgery
  • Adults under legal protection (judicial safeguard, curatorship, guardianship), persons deprived of liberty, pregnant or breastfeeding women, minors, and persons unable to provide informed consent
  • High risk of conversion to thoracotomy
  • Severe hepatic failure
  • Acute porphyria
  • Hypersensitivity to any of the active substances used for anaesthesia or to any excipient
  • Atrioventricular conduction disorders requiring permanent cardiac pacing that has not yet been performed
  • Adams–Stokes syndrome
  • Acute cerebrovascular disease, traumatic brain injury, or intracranial hypertension in the absence of controlled ventilation

结局指标

主要结局

Score obtained from the self-administered QoR-15 questionnaire at D1 after surgery. The questionnaire will be completed by the patient while blinded to the treatment group

Score obtained from the self-administered QoR-15 questionnaire at D1 after surgery. The questionnaire will be completed by the patient while blinded to the treatment group

次要结局

  • QoR-15 self-administered questionnaire score on postoperative day 0 (POD0) and postoperative day 1 (POD1)
  • Pain assessed using a standard Numeric Rating Scale (NRS) at rest and during coughing on POD0 (post-intervention), POD1, and POD2
  • Total dose of morphine administered postoperatively up to POD2
  •  Number of episodes of postoperative nausea and vomiting (PONV) requiring treatment up to POD2.  Time to return of bowel function (first postoperative flatus), censored at POD2.  Occurrence of postoperative cognitive dysfunction assessed on POD1 using the CAM (Confusion Assessment Method) or CAM-ICU validated in French.
  • Occurrence of postoperative pulmonary complications according to the Melbourne Group Scale (≥4 of 8 criteria)) within 28 days after surgery
  •  Forced Expiratory Volume per second (FEV₁) measured preoperatively (day −1) and on POD1 using a portable electronic spirometer.  Peak Expiratory Flow (PEF) measured preoperatively (day −1) and on POD1 using a portable electronic spirometer.  Forced Vital Capacity (FVC) measured preoperatively (day −1) and on POD1 using a portable electronic spirometer  Duration of postoperative oxygen therapy within the first 72 postoperative hours
  • Time to first patient mobilization (ambulation), censored at 28 days
  • Total length of hospital stay, censored at 28 days
  • Mortality at POD28
  •  Number of patients with chronic pain at 6 months postoperatively, assessed using a simplified DN4 questionnaire by telephone interview (DN2). DN2 considered positive if ≥3 positive answers out of 7. DN4 questionnaire considered positive if ≥4 positive answers out of 10.  Pain intensity assessed using the Numeric Rating Scale (NRS) at rest and during coughing at 6 months by telephone interview.  Analgesic consumption, including opioids
  • Occurrence of intraoperative cardiac events, including bradycardia (defined as episodes with heart rate <45 beats/min), hypotension (defined as mean arterial pressure <65 mmHg), and hypertension (defined as mean arterial pressure >90 mmHg)

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Grégoire LE GAC

Scientific

Centre Hospitalier Universitaire De Rennes

研究点 (5)

Loading locations...

相似试验